|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA & EMA (2014)) |
IUPAC Name ![]() |
| 5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9624 | idelalisib |
Synonyms ![]() |
| CAL-101/CAL101 |
| GS-1101 |
| Zydelig® |
Database Links ![]() |
|
| CAS Registry No. | 870281-82-6 (source: SciFinder) |
| ChEMBL Ligand | CHEMBL2216870 |
| PubChem CID | 11625818 |
| RCSB PDB Ligand | 40L |
| Search Google for chemical match using the InChIKey | IFSDAJWBUCMOAH-HNNXBMFYSA-N |
| Search Google for chemicals with the same backbone | IFSDAJWBUCMOAH |
| Search PubMed clinical trials | idelalisib |
| Search PubMed titles | idelalisib |
| Search PubMed titles/abstracts | idelalisib |
| Wikipedia | Idelalisib |
| Comments |
| Idelalisib is highly selective and potent oral inhibitor of phosphoinositide 3-kinase (PI3K) δ. |